日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NQO1/p65/CXCL12 Axis-Recruited Tregs Mediate Resistance to Anti-PD-1 Plus Lenvatinib Therapy in PIVKA-II-Positive Hepatocellular Carcinoma

NQO1/p65/CXCL12轴募集的调节性T细胞介导PIVKA-II阳性肝细胞癌对PD-1抑制剂联合乐伐替尼治疗的耐药性

Gao, Biao; Wang, Yafei; Sun, Zhuoya; Tang, Haowen; Cao, Yinbiao; Jiang, Hao; Zhang, Wenwen; Xu, Yinzhe; Hu, Bingyang; Liu, Zhe; Mao, Guankun; Li, Xuerui; Li, Junfeng; Wan, Tao; Liu, Bing; Zhao, Xiao; Jiao, Shunchang; Li, Chonghui; Lu, Shichun

Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial

恩伐利单抗联合卡铂和依托泊苷一线治疗广泛期小细胞肺癌的疗效、安全性及探索性生物标志物分析:一项前瞻性、单臂、II期试验

Zhao, Xiao; Zhang, Jing; Qiu, Lupeng; Han, Quanli; Yan, Xiang; Zhu, Yanyun; Wang, Jinliang; Zhang, Xiaoling; Jiao, Shunchang; Sun, Shengjie

Multi-omics analyses reveal interactions between GREM1+ fibroblasts and SPP1+ macrophages in gastric cancer

多组学分析揭示了胃癌中GREM1+成纤维细胞与SPP1+巨噬细胞之间的相互作用

Qiu, Lupeng; Zhao, Xiao; Yao, Sheng; Fei, Yang; Gong, Yixin; Zhou, Zishan; Jiao, Shunchang; Xu, Jianming

Development and validation of a novel nerve-related prognostic model for gastric cancer based on bulk and single-cell RNA sequencing data

基于批量和单细胞RNA测序数据,开发和验证一种新型的胃癌神经相关预后模型

Qiu, Lupeng; Yao, Sheng; Yang, Zizhong; Zhou, Zishan; Fei, Yang; Zhu, Xinyong; Liu, Feide; Gong, Yixin; Li, Shuang; Liu, Minglu; Zhao, Xiao; Jiao, Shunchang

Multi-omics analysis reveals the role of tumor-infiltrating CD4(+)CCR7(+) T cells in EGFR antibody resistance and prognosis of hepatocellular carcinoma.

多组学分析揭示了肿瘤浸润 CD4(+)CCR7(+) T 细胞在 EGFR 抗体耐药性和肝细胞癌预后中的作用。

Yang Zizhong, Qiu Lupeng, Jia Guhe, Sun Zhuoya, Gong Yixin, Chen Yin, Wang Yu, Song Lai, Zhao Xiao, Jiao Shunchang

Genomic and immunological profiling reveals novel prognostic biomarkers for limited-stage small cell lung cancer.

基因组和免疫学分析揭示了局限期小细胞肺癌的新型预后生物标志物

Li Ye, Ma Xiaolong, Wan Zhiyi, Bao Pengfei, Zhang Enli, Liu Lihua, Jiao Shunchang, Sun Shengjie

Short‑term efficacy assessment of brigatinib for the treatment of neurofibromatosis type 2: A retrospective study

布加替尼治疗2型神经纤维瘤病短期疗效评估:一项回顾性研究

Lin, Zhi; Yu, Wei; Jing, Fangfang; Xu, Zongyi; Liu, Minglu; Jiao, Shunchang

CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival

CXCL10和IL15共表达的嵌合抗原受体T细胞通过增加细胞毒性效应细胞的积累和存活,增强胃癌的抗肿瘤作用。

Nie, Siyue; Song, Yujie; Hu, Kun; Zu, Wei; Zhang, Fengjiao; Chen, Lixia; Ma, Qiang; Zhou, Zishan; Jiao, Shunchang

Single-cell RNA sequencing reveals intratumoral heterogeneity and multicellular community in primary hepatocellular carcinoma underlying microvascular invasion

单细胞RNA测序揭示原发性肝细胞癌中肿瘤内异质性和多细胞群落,揭示其与微血管侵袭的关系。

Sun, Zhuoya; Gao, Biao; Song, Lai; Wang, Biying; Li, Junfeng; Jiang, Hao; Li, Xuerui; Yu, Yang; Zhou, Zishan; Yang, Zizhong; Sun, Xiaohui; Jiao, Tianyu; Zhao, Xiao; Lu, Shichun; Jiao, Shunchang

Nomograms Predict PFS and OS for SCLC Patients After Standardized Treatment: A Real-World Study

列线图预测小细胞肺癌患者标准化治疗后的无进展生存期和总生存期:一项真实世界研究

Li, Ke; Qiu, Lupeng; Zhao, Yang; Sun, Xiaohui; Shao, Jiakang; He, Chang; Qin, Boyu; Jiao, Shunchang